According to Seagen 's latest financial reports the company's current earnings (TTM) are -$0.8 B. In 2022 the company made an earning of -$0.62 B an increase over its 2021 earnings that were of -$0.69 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.8 B | 28.97% |
2022 | -$0.62 B | -10.13% |
2021 | -$0.69 B | -214.28% |
2020 | $0.59 B | -370.63% |
2019 | -$0.23 B | -15.17% |
2018 | -$0.26 B | 32.79% |
2017 | -$0.2 B | 37.19% |
2016 | -$0.15 B | 18% |
2015 | -$0.13 B | 56.34% |
2014 | -$77.37 M | 23.07% |
2013 | -$62.87 M | |
2011 | -$0.15 B | 111.72% |
2010 | -$68.2 M | -19.63% |
2009 | -$84.86 M | -7.55% |
2008 | -$91.79 M | 64.95% |
2007 | -$55.65 M | 38.4% |
2006 | -$40.21 M | 25.36% |
2005 | -$32.08 M | -14.86% |
2004 | -$37.67 M | 61.92% |
2003 | -$23.27 M | -7.67% |
2002 | -$25.2 M | 6.76% |
2001 | -$23.6 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Pfizer PFE | $3.26 B | -513.24% | ๐บ๐ธ USA |
AbbVie ABBV | $6.25 B | -890.56% | ๐บ๐ธ USA |
Biogen BIIB | $1.29 B | -264.03% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $8.44 B | -1,167.58% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $7.53 B | -1,053.11% | ๐ฌ๐ง UK |
Spectrum Pharmaceuticals
SPPI | -$61.89 M | -92.17% | ๐บ๐ธ USA |
ImmunoGen
IMGN | -$62.78 M | -92.06% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | -$0.15 B | -82.03% | ๐บ๐ธ USA |